Clinical Trial Update: Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating TAK-559 plus glyburide in Type 2 diabetes mellitus was terminated; the update reports efficacy and safety data observed before terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glyburide (glyburide)
• TAK-559

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: TERMINATED